In the present scenario, pharmaceutical and biomedical sectors are facing the challenges of continuous increase in the multidrug‐resistant (MDR) human pathogenic microbes. Re‐emergence of MDR microbes is facilitated by drug and/or antibiotic resistance, which is acquired way of microbes for their survival and multiplication in uncomfortable environments. MDR bacterial infections lead to significant increase in mortality, morbidity and cost of prolonged treatments. Therefore, development, modification or searching the antimicrobial compounds having bactericidal potential against MDR bacteria is a priority area of research. Silver in the form of various compounds and bhasmas have been used in Ayurveda to treat several bacterial infections since time immemorial. As several pathogenic bacteria are developing antibiotic resistance, silver nanoparticles are the new hope to treat them. This review discusses the bactericidal potential of silver nanoparticles against the MDR bacteria. This multiactional nanoweapon can be used for the treatment and prevention of drug‐resistant microbes.
1 December 2009 in Nanomedicine: Nanotechnology, Biology and Medicine
We report extracellular mycosynthesis of silver nanoparticles by Fusarium acuminatum Ell. and Ev. (USM-3793) isolated from infected ginger (Zingiber officinale). An aqueous silver nitrate solution was reduced to metallic silver when exposed to F. acuminatum cell extract leading to the appearance of a brown color within 15-20 minutes. The color is due to the formation of silver nanoparticles and the excitation of surface plasmons. The optical spectrum showed the plasmon resonance at 420 nm and analysis by transmission electron microscopy confirmed the presence of silver nanoparticles. The nanoparticles produced were spherical with a broad size distribution in the range of 5-40 nm with average diameter of 13 nm. The reduction of the silver ions occurs probably by a nitrate-dependent reductase enzyme, which we found to be present in the extra-cellular medium. We tested the silver particles for their broad-band antibacterial activity on different human pathogens. We observed efficient antibacterial activity against multidrug resistant and highly pathogenic bacteria, including multidrug resistant Staphylococcus aureus, Salmonella typhi, Staphylococcus epidermidis, and Escherichia coli. The synthesis of silver nanoparticles by the fungus F. acuminatum may therefore serve as a simple, cheap, eco-friendly, reliable and safe method to produce an antimicrobial material.
12 April 2011 in Applied Microbiology and Biotechnology